BARCLAYS PLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 1 filers reported holding RAPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$892
-26.0%
53,651
-16.7%
0.00%0.0%
Q2 2023$1,205
+31.4%
64,436
+28.8%
0.00%
Q1 2023$917
-41.9%
50,034
-37.2%
0.00%
-100.0%
Q4 2022$1,577
-99.9%
79,652
+76.9%
0.00%0.0%
Q3 2022$1,084,000
+2158.3%
45,026
+1610.7%
0.00%
Q2 2022$48,000
-91.7%
2,632
-90.0%
0.00%
Q1 2022$580,00026,3700.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$53,076,29617.67%
Euclidean Capital LLC 432,900$8,571,4208.02%
GREAT POINT PARTNERS LLC 1,436,569$28,444,0665.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 880,000$17,424,0003.47%
Trustees of Columbia University in the City of New York 73,383$1,4533.00%
Cheyne Capital Management (UK) LLP 71,828$1,422,1942.48%
Deep Track Capital, LP 1,304,940$25,837,8121.08%
Ghost Tree Capital, LLC 125,000$2,475,0001.06%
Perceptive Advisors 1,798,955$35,619,3091.00%
BRAIDWELL LP 1,000,000$19,800,0000.66%
View complete list of RAPT THERAPEUTICS INC shareholders